Slc7a8^{tm2c(EUCOMM)Hmgu}
Targeted Allele Detail

Summary

• Symbol: Slc7a8^{tm2c(EUCOMM)Hmgu}
• Name: solute carrier family 7 (cationic amino acid transporter, y+ system), member 8; targeted mutation 2c, Helmholtz Zentrum Muenchen GmbH
• MGI ID: MGI:7443009
• Synonyms: Slc7a8^fl
• Gene: Slc7a8 Location: Chr14:54959672-55019343 bp, - strand Genetic Position: Chr14, 27.91 cM
• Alliance: Slc7a8^{tm2c(EUCOMM)Hmgu} page
• IMPC: Slc7a8 gene page

Mutation origin

• Germline Transmission: Earliest citation of germline transmission: J:333885
• Parent Cell Line: JM8.N4 (ES Cell)
• Strain of Origin: C57BL/6N
• Project Collection: EUCOMM

Mutation description

• Allele Type: Targeted (Conditional ready)
• Mutation: Insertion
• Mutation details: The L1L2_Bact_P cassette was inserted at position 54996814 of Chromosome 14 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 54997477. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele was created by flp recombinase expression in mice carrying this allele to remove the lacZ sequence and neo selection cassette, leaving loxP sites flanking the critical exon(s). Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml (J:333885)

Find Mice (IMSR)

• Mouse strains and cell lines available from the International Mouse Strain Resource (IMSR)
• Carrying this Mutation: Mouse Strains: 0 strains available Cell Lines: 0 lines available
• Carrying any Slc7a8 Mutation: 31 strains or lines available

References

• Original: J:333885 Hodge SH, et al., Amino acid availability acts as a metabolic rheostat to determine the magnitude of ILC2 responses. J Exp Med. 2023 Mar 6;220(3)
• All: 2 reference(s)